|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/00 | |||
| A61K 38/10 | |||
| A61K 39/00 |
| (11) | Number of the document | 3233104 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15871075.6 |
| Date of filing the European patent application | 2015-12-17 | |
| (97) | Date of publication of the European application | 2017-10-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/066400 |
| Date | 2015-12-17 |
| (87) | Number | WO 2016/100679 |
| Date | 2016-06-23 |
| (30) | Number | Date | Country code |
| 201462094944 P | 2014-12-19 | US |
| (72) |
EGGINK, Laura L., US
HOOBER, J. Kenneth, US
|
| (73) |
Susavion Biosciences, Inc.,
1615 W. University Drive, Suite 132, Tempe, AZ 85281,
US
|
| (54) | IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS |
| IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS |